Evidence map›Paper›PMID 33397967›Full record

ArticleNature communications2021

ZNF143 mediates CTCF-bound promoter-enhancer loops required for murine hematopoietic stem and progenitor cell function.

Qiling Zhou, Miao Yu, Roberto Tirado-Magallanes, Bin Li, Lingshi Kong, Mingrui Guo, Zi Hui Tan, Sanghoon Lee, Li Chai, Akihiko Numata and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 5 countries.

Qiling ZhouCancer Science Institute of Singapore, National University of Singapore, 117599, Singapore, Singapore.ORCID 0000-0001-6639-8590
Miao YuSchool of Life Sciences, Fudan University, Shanghai, China.
Roberto Tirado-MagallanesCancer Science Institute of Singapore, National University of Singapore, 117599, Singapore, Singapore.
Bin LiLudwig Institute for Cancer Research, La Jolla, CA, 92093, USA.
Lingshi KongCancer Science Institute of Singapore, National University of Singapore, 117599, Singapore, Singapore.
Mingrui GuoCancer Science Institute of Singapore, National University of Singapore, 117599, Singapore, Singapore.
Zi Hui TanCancer Science Institute of Singapore, National University of Singapore, 117599, Singapore, Singapore.
Sanghoon LeeCancer Science Institute of Singapore, National University of Singapore, 117599, Singapore, Singapore.
Li ChaiDepartment of Pathology, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Akihiko NumataCancer Science Institute of Singapore, National University of Singapore, 117599, Singapore, Singapore.
Touati BenoukrafCancer Science Institute of Singapore, National University of Singapore, 117599, Singapore, Singapore.ORCID 0000-0002-4789-8028
Melissa Jane FullwoodCancer Science Institute of Singapore, National University of Singapore, 117599, Singapore, Singapore.
Motomi OsatoCancer Science Institute of Singapore, National University of Singapore, 117599, Singapore, Singapore.ORCID 0000-0003-3982-9054
Bing RenLudwig Institute for Cancer Research, La Jolla, CA, 92093, USA.ORCID 0000-0002-5435-1127
Daniel G TenenCancer Science Institute of Singapore, National University of Singapore, 117599, Singapore, Singapore. daniel.tenen@nus.edu.sg.ORCID 0000-0002-6423-3888
National University of Singapore · SGAgency for Science, Technology and Research · SGBrigham and Women's Hospital · USFudan University · CNHarvard University · USKyushu University · JPLudwig Cancer Research · USMemorial University of Newfoundland · CAThe University of Texas MD Anderson Cancer Center · USUniversity of California San Diego · US

Funding

Transcriptional and epigenetic heterogeneity of stem/progenitor cellsP01HL131477 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI David T Scadden · 2017 to 2026
$24.6M
Mechanisms of regulation by RNA in acute myeloid leukemiaR35CA197697 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TENEN, DANIEL G · 2015 to 2021
$7.1M
NCI NIH HHS R35 CA197697NHLBI NIH HHS P01 HL131477
6 · The paper itself

Abstract

CCCTC binding factor (CTCF) is an important factor in the maintenance of chromatin-chromatin interactions, yet the mechanism regulating its binding to chromatin is unknown. We demonstrate that zinc finger protein 143 (ZNF143) is a key regulator for CTCF-bound promoter-enhancer loops. In the murine genome, a large percentage of CTCF and ZNF143 DNA binding motifs are distributed 37 bp apart in the convergent orientation. Furthermore, deletion of ZNF143 leads to loss of CTCF binding on promoter and enhancer regions associated with gene expression changes. CTCF-bound promoter-enhancer loops are also disrupted after excision of ZNF143. ZNF143-CTCF-bound promoter-enhancer loops regulate gene expression patterns essential for maintenance of murine hematopoietic stem and progenitor cell integrity. Our data suggest a common feature of gene regulation is that ZNF143 is a critical factor for CTCF-bound promoter-enhancer loops.

Indexed as

Enhancer Elements, GeneticPromoter Regions, GeneticAnimalsCCCTC-Binding FactorDNAHematopoiesisHematopoietic Stem CellsMiceMice, Inbred C57BLMice, KnockoutPhenotypeProtein BindingProtein StabilityTrans-ActivatorsTranscription, GeneticCCCTC-Binding FactorCtcf protein, mouseDNATrans-Activators

Identifiers

PMID33397967
PMCPMC7782510
OpenAlexW3120635680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.